Immucor, Inc.

Immucor, Inc. is a global leader in transfusion and transplant diagnostics, established in 1982 and based in Norcross, Georgia. The company develops innovative diagnostic solutions aimed at enhancing the safety and efficiency of blood transfusions and organ transplants. Immucor focuses on improving patient-donor compatibility through advanced testing technologies and automation in blood bank operations. The company offers a wide range of products, including automated blood bank instruments like the ABS2000 and the Galileo system, which are designed for high-volume processing in hospitals and clinical laboratories. Immucor's patented Capture solid phase technology enables sensitive antibody screening and identification assays, while their expansion into molecular immunohematology enhances transfusion medicine through DNA typing. Immucor serves hospital transfusion centers, blood donor centers, and large clinical laboratories, providing reliable testing platforms that improve diagnostic accuracy and operational efficiency. In 2022, Immucor was acquired by Werfen, further strengthening its position in specialized diagnostics.

• Employees 520
• Founded 1982